A new iPSC-derived cellular tool with built-in Cas9 expression enables high efficiency knockout screening for drug target identification and validation. Functional genomics screening that leverages ...

Innovation enabled by proprietary STAR-CRISPR™ gene editing technology The ... "Allo Chassis™ provides therapeutic developers with iPSC starting material featuring the most commonly used ...

CRISPR is a technology that allows scientists to "selectively modify the DNA of living organisms," according to the National Human Genome Research Institute. The image is a fabrication ...

With two high-impact platforms, CRISPR/TARGATT ™ genome editing and induced pluripotent stem cell (iPSC) (good manufacturing practice (GMP) grade), they seek to help advance the development of novel ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, providing insights into its DNA recognition and cleavage mechanisms.

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

Its focus and expertise in iPSC reprogramming, gene editing using its proprietary STAR-CRISPR™ technology and differentiation development, positions the company to be the partner of choice for ...

With ready-to-use, immune-cloaked CD34+ and CD4+ T-cell derived iPSC cell lines, this new offering paves the way for faster market-ready therapies, ultimately improving patient access to essential ...